Gilder Gagnon Howe & Co’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-6,022
| Closed | -$135K | – | 278 |
|
|
2018
Q1 | $135K | Sell |
6,022
-106,604
| -95% | -$2.39M | ﹤0.01% | 268 |
|
|
2017
Q4 | $3.39M | Sell |
112,626
-10,545
| -9% | -$317K | 0.05% | 180 |
|
|
2017
Q3 | $4.64M | Buy |
123,171
+111,982
| +1,001% | +$4.22M | 0.07% | 151 |
|
|
2017
Q2 | $312K | Buy |
11,189
+2,243
| +25% | +$62.5K | ﹤0.01% | 232 |
|
|
2017
Q1 | $308K | Buy |
8,946
+7,975
| +821% | +$275K | 0.01% | 228 |
|
|
2016
Q4 | $28K | Sell |
971
-4,658
| -83% | -$134K | ﹤0.01% | 258 |
|
|
2016
Q3 | $179K | Buy |
5,629
+990
| +21% | +$31.5K | ﹤0.01% | 233 |
|
|
2016
Q2 | $151K | Sell |
4,639
-32
| -0.7% | -$1.04K | ﹤0.01% | 237 |
|
|
2016
Q1 | $131K | Sell |
4,671
-134,363
| -97% | -$3.77M | ﹤0.01% | 207 |
|
|
2015
Q4 | $4.96M | Sell |
139,034
-168,797
| -55% | -$6.02M | 0.08% | 122 |
|
|
2015
Q3 | $10.2M | Sell |
307,831
-3,353
| -1% | -$111K | 0.16% | 100 |
|
|
2015
Q2 | $13M | Sell |
311,184
-6,051
| -2% | -$253K | 0.17% | 93 |
|
|
2015
Q1 | $10.3M | Sell |
317,235
-1,357,327
| -81% | -$44.2M | 0.14% | 101 |
|
|
2014
Q4 | $53.2M | Sell |
1,674,562
-14,327
| -0.8% | -$455K | 0.79% | 39 |
|
|
2014
Q3 | $41.8M | Sell |
1,688,889
-23,164
| -1% | -$574K | 0.61% | 48 |
|
|
2014
Q2 | $38.7M | Sell |
1,712,053
-397,311
| -19% | -$8.98M | 0.51% | 51 |
|
|
2014
Q1 | $51.3M | Buy |
2,109,364
+49,835
| +2% | +$1.21M | 0.7% | 47 |
|
|
2013
Q4 | $51.5M | Buy |
2,059,529
+380,353
| +23% | +$9.51M | 0.73% | 40 |
|
|
2013
Q3 | $46.1M | Sell |
1,679,176
-26,332
| -2% | -$723K | 0.72% | 46 |
|
|
2013
Q2 | $31M | Buy |
+1,705,508
| New | +$31M | 0.58% | 53 |
|